Board of Directors
Dipak Chattaraj, Director. On August 2, 2011, Dipak Chattaraj was appointed to the company’s board of directors. Mr. Chattaraj was formerly the chairman of Ranbaxy USA, a global generic pharmaceutical company. With over 35 years of global experience, Mr. Dipak Chattaraj has played a key role in Ranbaxy’s global expansion, specifically in the US markets development. Mr. Chattaraj joined Ranbaxy in 1991and in 1996 he assumed responsibility for Ranbaxy’s U.S. operations. Mr. Chattaraj, who holds a Masters degree in Economics, recently retired as Ranbaxy’s President, Corporate Development.